DVA Stock Analysis: Buy, Sell, or Hold?

DVA - DaVita Inc.

SERVICES-MISC HEALTH & ALLIED SERVICES, NEC
$109.78
0.44 (0.40%) ▲
5d: +2.11%
30d: -3.37%
90d: -7.55%
BUY
HIGH Confidence
Last Updated: February 2, 2026
Earnings: Feb 02, 2026 0d

Get Alerted When DVA Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: DVA shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$194.67
Based on 11.6% avg growth
INTRINSIC VALUE TODAY
$120.88
9.2% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.9x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: DVA is currently trading at $109.78, which is considered fair relative to its 30-day fair value range of $105.73 to $113.03. The stock's valuation (Forward PE: 8.6) is in line with its historical norms (8.9). Remarkably, the market is currently pricing in an annual earnings decline of 1.3% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, DVA is in a strong downtrend. The price is approaching resistance at $111.15. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: DVA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $143.00 (+30.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Fair Price Range $105.73 - $113.03
Company Quality Score 67/100 (BUY)
Volume Confirmation HIGH
Confidence Score 83.3%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 30.8% below Wall St target ($143.00)

Fair Price Analysis

30-Day Fair Range $105.73 - $113.03
Current vs Fair Value FAIR

Support & Resistance Levels

Support Level $103.48
Resistance Level $111.15
Current Trend Strong Downtrend

Fundamental Context

Forward P/E (Next Year Est.) 8.58
Wall Street Target $143.00 (+30.8%)
Revenue Growth (YoY) 4.8%
Earnings Growth (YoY) -18.4%
Profit Margin 5.8%
Valuation Discount vs History -1.3% cheaper
PE vs Historical 8.6 vs 8.9 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -1.3% (market-implied from PE analysis)
1-Year Target $107.92 (-1%)
2-Year Target $106.52 (-3%)
3-Year Target $105.13 (-4%)
3-Yr Target (if PE normalizes) (PE: 9→9) $108.99 (0%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.3, Growth: 19.1%) $480.24 (+339%)
Base: (SPY PE: 8.6, Growth: 19.1%) $184.87 (+69%)
Bear: (PE: 7.3, Growth: 19.1%) $157.14 (+44%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (11x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Trailing PE: 10.93 | Current EPS (TTM): $9.69
Bull Case $153.09 (+40%)
Analyst growth 31.4%, PE expands to 12.0
Base Case $139.17 (+27%)
Market implied 31.4%, PE stable at 10.9
Bear Case $72.00 (-34%)
Severe decline -20.0%, PE contracts to 9.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.6 to 8.9
Stabilization Target: $113.36 (+3.7%)
PE Expansion Potential: +3.7%
Last updated: February 02, 2026 2:37 PM ET
Data refreshes hourly during market hours. Next update: 3:37 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Julie Johnson SELL 2025-09-25
Ro Khanna SELL 2025-09-05

Featured in Portfolios

DVA is a key holding in these high-performance investment strategies.

Top Rated Medical Care Facilities Stocks

Top-rated stocks in Medical Care Facilities by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
HCA
HCA Holdings Inc
BUY
25 analysts
$529 62 BUY
THC
Tenet Healthcare Corpora…
STRONG BUY
22 analysts
$238 54 HOLD
EHC
Encompass Health Corp
STRONG BUY
12 analysts
$140 58 HOLD
CMPS
Compass Pathways Plc
STRONG BUY
11 analysts
$17 50 HOLD
CON
Concentra Group Holdings…
STRONG BUY
8 analysts
$28 61 BUY

Advanced DVA Option Strategies

Professional options setups generated by AI based on today's DVA price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for DVA

DVA Technical Chart DVA Price Prediction DVA Earnings Date DVA Investment Advisor DVA Fair Price Analyzer DVA Options Advisor DVA Options Chain DVA Options Analysis DVA Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals